Stock vs Stock Comparison

DaVita Inc. vs Abbott Laboratories

DVA wins the Tale of the Tape 6–3.

DVA$195.03
ABT$86.99

🏆 Tale of the Tape

63
DVAABT
5.5%Profitability (Net Margin)14.7%
18.7xValuation (P/E)24.0x
10.6%Efficiency (ROIC)10.1%
6/9Health (Piotroski F)5/9
1.5Safety (Altman Z)4.9
6.5%Growth (Rev YoY)5.7%
0.01Risk (Sharpe 1Y)-1.05
14.09xBalance Sheet (D/E)0.64x
6.71%FCF Yield4.21%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.074
252-Day Correlation
0.044
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricDVAABT
Market Cap$12.5B$149.1B
P/E Ratio18.7x24.0x
Forward P/E11.3x14.1x
P/B-17.03x2.86x
Dividend Yield2.94%
Beta0.840.65

Quantitative Metrics

MetricDVAABT
DCF Fair Value$623.96$57.20
DCF Upside+311.7%-43.2%
Piotroski F6/95/9
Altman Z1.554.87
Beneish M-2.67-2.53
FCF Yield6.71%4.21%
Net Debt/EBITDA3.6x0.1x
ROIC10.6%10.1%
WACC7.2%9.4%
ROIC – WACC3.4pp0.7pp
Gross Margin32.3%56.4%
Net Margin5.5%14.7%
Rev Growth YoY6.5%5.7%
Sharpe (1Y)0.01-1.05
Max Drawdown 3Y
FCF Payout Ratio56%

DVA Price

Loading chart...

ABT Price

Loading chart...

ETF Exposure

DVA found in:

XHS2.31%
RSP0.18%
ONEV0.18%
XLV0.12%
VBR0.12%
VHT0.10%
ONEO0.05%
SPYV0.02%
VONG0.02%
IWF0.02%
SCHV0.02%
SPY0.01%
VOO0.01%
SCHX0.01%
SCHB0.01%
SPLG0.01%
SPTM0.01%
IVV0.01%
ITOT0.01%

ABT found in:

IHI16.06%
IYH2.88%
XLV2.85%
VHT2.55%
DGRW1.71%
XHE1.36%
NOBL1.34%
SDY0.99%
MGV0.78%
VIG0.71%
VFMV0.69%
SCHV0.68%
VYM0.65%
VTV0.61%
IWD0.58%
QUS0.57%
SPYV0.53%
VONV0.48%
IVV0.37%
SPLG0.37%
ESGV0.36%
ITOT0.33%
SCHX0.33%
SCHB0.30%
VOO0.26%
VONE0.24%
SPY0.24%
URTH0.24%
VTI0.23%
SPTM0.22%
ACWI0.20%
RSP0.17%
VT0.14%
ONEO0.08%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

DVA vs ABT: Head-to-Head Analysis

DaVita Inc. (DVA) and Abbott Laboratories (ABT) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, DVA leads 6–3 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, DVA generates a return on invested capital (ROIC) of 10.6% compared to ABT's 10.1%. This suggests DVA is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between DVA and ABT is 0.074, indicating low correlation, making them an effective diversification pair in a portfolio context.

DVA appears in 19 ETFs tracked by SecuritiesDB, while ABT appears in 34 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, DVA or ABT?

Our quantitative analysis compares DVA and ABT across nine fundamental dimensions. DVA wins the Tale of the Tape 6–3. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are DVA and ABT correlated?

The 252-day correlation between DVA and ABT is 0.074. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.